Kinnate Biopharma Inc. (KNTE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kinnate Biopharma Inc., with annual and quarterly history.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.98x | -2.36x | -8.64x | -48.81x | -141.80x | -221.63x |
| P/B Ratio | 0.69x | 1.20x | 2.42x | 4.40x | -96.71x | 222.22x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 13.19x | 13.45x | 20.88x | 54.79x | 39.82x | 17.30x |
| Quick Ratio | 13.19x | 13.45x | 20.88x | 54.79x | 39.82x | 17.30x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..